簡易檢索 / 詳目顯示

研究生: 蜜安妮
Misliani,
論文名稱: 三維介電泳微流體晶片於登革熱病毒感染之臨床試樣快速檢測的應用探討
3D Dielectrophoretic microfluidic chip for rapid clinical diagnosis of dengue infection
指導教授: 張憲彰
Chang, Hsien-Chang
學位類別: 碩士
Master
系所名稱: 工學院 - 生物醫學工程學系
Department of BioMedical Engineering
論文出版年: 2019
畢業學年度: 107
語文別: 英文
論文頁數: 48
中文關鍵詞: 二電泳免疫測定登革熱病毒檢測螢光
外文關鍵詞: Dielectrophoresis, immunoassay, dengue virus detection, Fluorescence
相關次數: 點閱:79下載:6
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 登革熱是一種新興的病毒感染,每年在世界各地增加。據世界衛生組織 (WHO) 稱,當登革熱病毒通過蚊子傳播時,病毒可在發病後4至5天內在血清、血漿、迴圈血細胞和其他組織中檢測到。因此,快速、靈敏、準確的登革熱感染診斷結果仍然是提供適當治療和管理的關鍵問題。本研究介紹了基於微流體二電泳(DEP)晶片的登革熱病毒(DENV)感染診斷。本研究使用的方法為流體動力學和DEP力,允許4G2塗層珠子和在設計晶片上標有螢光標記的DENV顆粒之間的免疫反應。利用DEP力捕獲微流體晶片中流動的修飾珠子(抗黃病毒單克隆抗體塗層珠子),用螢光標籤修飾的DENV可以通過免疫反應在改性珠子上捕獲。然後,通過ImageJ分析軟體對獲得的螢光信號進行量化。在DEP晶片上僅需要少量樣品(10-15 μL)來檢測DENV。該平臺可加速免疫反應時間,其中片上檢測時間小於3分鐘,並證明利用臨床登革熱病毒(DENV)樣本的DENV檢測能力低至102 pfu/mL。

    Dengue is an emerging viral infection that is increasing annually worldwide. According to World Health Organization (WHO), when the dengue viruses are transferred by the mosquito-borne to humans, the virus can be detected in serum and plasma, circulating blood cells and other tissues for 4 - 5 days after the onset of febrile illness. Hence, a rapid, sensitive and accurate result of the dengue infection diagnosis is a crucial tool to provide proper treatment, prevention, and management to the disease. In this study, the diagnosis of dengue virus (DENV) infection based on microfluidic dielectrophoresis (DEP) chip was introduced. The method used in this study was hydrodynamic and DEP forces to allow the immuno-reaction between 4G2-coated beads and fluorescence-labeled DENV particles on the designed chip. The DEP force was employed to capture the modified beads (anti-flavivirus monoclonal antibody-coated beads) flowing in the microfluidic chip and the DENV modified with fluorescence label could be captured on the modified beads by immunoreaction. The obtained fluorescent signal was then quantified by ImageJ analysis software. A small amount of sample (10 - 15 μL) was needed for DENV detection on the DEP chip. The platform can be used to accelerate an immuno-reaction time, in which the on-chip detection time was less than 3 min, demonstrating an ability for DENV detection as low as 102 pfu/mL using the clinical dengue virus (DENV) sample.

    Abstract I 中文摘要 II Acknowledgements III Contents IV List of Figures VI List of Tables VIII Chapter 1 Introduction 1 1.1 Background 1 1.1.1 Development of dengue virus in the infected human body 3 1.1.2 Clinical diagnostic 3 1.2 Current dengue detection methods 4 1.2.1 Virus isolation 4 1.2.2 Nucleic acid amplification 5 1.2.3 Detection of antigens 6 1.3 Theory of dielectrophoresis (DEP) 8 1.3.1 Dielectrophoresis on polarized particles 8 1.3.2 Dielectrophoresis on biological particles 9 1.3.3 Fluid flow in dielectrophoresis microchannel 11 1.4 Motivation and aims 13 Chapter 2 Material and Methods 14 2.1 Chip fabrication 14 2.2 Anti-flavivirus monoclonal antibody (4G2) immobilized on silica beads 18 2.3 Sample preparation 20 2.3.1 Dengue virus labelling with fluorescence probe 20 2.2.2 Dilution series and conductivity adjustment 22 2.2.3 Fluorescence test 22 2.4 Experimental configuration 24 2.4.1 Chip pretreatment 24 2.4.2 Experiment set up 24 2.5 Image analysis by ImageJ analysis software 26 Chapter 3 Results and Discussion 27 3.1 DEP chip parameters optimization 27 3.1.1 Effect of conductivity on DEP chip performance 27 3.1.2 DEP chip performance test 28 3.2 Application of DEP chip for in vitro DENV detection 32 3.2.1 In vitro DENV fluorescence intensity detection on the DEP chip 32 3.2.2 Limit of detection of the in vitro DENV detection on the DEP chip 35 3.3. DEP chip for first passage (P1) DENV detection 37 3.3.1 P1 DENV fluorescence intensity detection on the DEP chip 37 3.3.2 Limit of detection of the P1 DENV detection on the DEP chip 39 3.4 Detection of DENV spike into human plasma 41 3.4.1 Diversity of the human plasma conductivity 41 3.4.2 DENV spiked in plasma detection on DEP chip 43 Chapter 4 Conclusion and Prospect 47 References IX Personal Information XIII

    [1] M. Guzman, S. Halstead, H. Artsob, P. Buchy, J. Farrar, D. Gubler, E. Hunsperger, A. Kroeger, H. Margolis, E. Martinez, M. Nathan, J. Pelegrino, C. Simmons and R. Peeling, "Dengue: a continuing global threat," Nature Reviews Microbiology, vol. 8, pp. S7- S16, 2010.
    [2] S.-F. Wang, W.-H. Wang, K. Chang, Y.-H. Chen, S.-P. Tseng, C.-H. Yen, D.-C. Wu and Y.-M.-A. Chen, "Severe dengue fever outbreaks in Taiwan," American Journal of Tropical Medicine and Hygiene, vol. 94, no. 1, pp. 193-197, 2016.
    [3] WHO, "Dengue: guidelines for diagnosis, treatment, prevention and control," in Laboratory diagnosis and diagnostic test, Geneve, WHO Press, 2009, pp. 89-170.
    [4] E. Iswardy, "Dielectrophoresis-based microfluidic biochip for rapid diagnosis of dengue infection," National Cheng Kung University, Tainan, Taiwan, 2017.
    [5] I.-F. Cheng, H.-W. Han and H.-C. Chang, "Dielectrophoresis and shear-enhanced sensitivity and selectivity of DNA hybridization for rapid discrimination of Candida species.," Biosensors and Bioelectronics, vol. 33, no. 1, pp. 36-43, 2012.
    [6] C. Qian, H. Huang, L. Chen, X. Li, Z. Ge, T. Chen, and Yan, "Dielectrophoresis for bioparticle manipulation.," International Journal of Molecular Science, vol. 15, no. 10, pp. 18281-18309, 2014.
    [7] E. Iswardy, T.-C. Tsai, H.-C. Chang, T.-C. Ho and G.-C. Perng, "A bead-based immunofluorescence-assay on a microfluidic dielectrophoresis platform for rapid dengue virus detection," Biosensors and Bioelectronics, vol. 95, pp. 174-180, 2017.
    [8] S. De la Cruz-Hernandez, H. Flores-Aguilar, S. Gonzalez-Mateos, I. Lopez-Martinez, C. Alpuche-Aranda, J. E. Ludert and R. M. del Angel, "Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico," American Journal of Tropical Medicine and Hygiene, vol. 88, no. 3, pp. 446-454, 2013.
    [9] N. Modhiran, D. Watterson and D. A. Muller, "Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity," Science Translational Medicine, vol. 7, no. 304, pp. 7 - 12, 2015.
    [10] D.-A. Muller, A.-C. Depelsenaire and P.-R. Young, "Clinical and laboratory diagnosis of dengue virus infection," Journal of Infectious Disease, vol. 215, no. 2, pp. 89-95, 2017.
    [11] P.-Y. Shu and J.-H. Huang, "Current advances in dengue diagnosis," Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 4, pp. 642-650, 2004.
    [12] M. G. Guzman and G. Kouri, "Dengue diagnosis, advances, and challenges," International Journal of Infectious Diseases, vol. 8, no. 2, pp. 69-80, 2004.
    [13] e. a. Lanciotti RS, "Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction," Journal of Clinical Microbiology, vol. 30, pp. 545-551, 1992.
    [14] D.-H. Library and P.-R. Young, "High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever," Journal of Infectious Diseases, vol. 186, no. 8, pp. 1165 - 1168, 2002.
    [15] R. Peeling, H. Artsob, J. Pelegrino, P. Buchy, M. Cardosa, Devi, S., D. Enria, J. Farrar, D. Gubler, M. Guzman, and S. Halstead, "Evaluation of diagnostic tests: dengue," Nature Reviews Microbiology, vol. 8, pp. S30-S37, 2010.
    [16] N. Green and A. Ramos, "Electrokinnetics and hydrodynamics in the microsystem," in Dielectrophoresis and AC electrokinetics, New York, Springer-Verlag Wien, 2011, pp. 61 - 84.
    [17] L.-Y. Chu, R. Xie, X.-J. Ju and W. Wang, "Characterization of wettability and roughness of modified glass microchannel," in Smart hydrogel functional materials, Beijing, Springer Heidelberg, and Chemical Industry Press, 2013, pp. 78-84.
    [18] A. Karimi, S. Yazdi, and A. Ardekani, "Hydrodynamic mechanisms of cell and particle trapping in microfluidics," Biomicroflidics, vol. 7, no. 2, pp. 21501 - 215023, 2013.
    [19] I.-F. Cheng, H.-C. Chang, D. Hou, and H.-C. Chang, "An integrated dielectrophoretic chip for continuous bioparticle filtering, focusing, sorting, trapping, and detecting.," Biomicrofluidics, vol. 1, no. 2, pp. 1 - 14, 2007.
    [20] B. Albert, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, "Pathogens, Infection, and Innate Immunity," in Molecular biology of the cell, New York, Garland Science Press, 2008, pp. 1350 - 1387.
    [21] D.-H. Clarke and J. Casals, "Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses," American Journal of Tropical Medicine and Hygiene, vol. 7, no. 5, pp. 561-573, 1958.
    [22] A. Foudeh, T. Fatanat Didar, T. Veres and M. Tabrizian, "Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics," Lab on a Chip, vol. 12, no. 18, pp. 3249-3266, 2012.
    [23] D. Gubler, W. Suharyono, R. Tan, M. A. and A. Sie, "Viraemia in patients with naturally acquired dengue infection," Bulletin of World Health Organization, vol. 59, no. 4, pp. 623-630, 1981.
    [24] S. Pal, A. Dauner, I. Mitra, B. Forshey, P. Gracia, A. Morrison, E. Halsey, T. Kochel, and S. Wu, "Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples," PLoS ONE, vol. 9, no. 11, pp. 394 - 341, 2014.
    [25] G. Whitesides, "The origins and the future of microfluidics," Nature, vol. 442, no. 7101, pp. 368-373, 2006.
    [26] T. B. Jones, "Electrical force and torques on bioparticles," Electrostatics, vol. 143, pp. 135-144, 1995.
    [27] P. Jonhson, P. Olofsson, and Tjarnhage, "Bioaerosol detection technologies," in Trends in biological detection, New York, Springer-Verlag New York, 2014, pp. 317 - 322.

    下載圖示 校內:立即公開
    校外:立即公開
    QR CODE